
|Articles|August 15, 2003
NYEEI's Ritch elected to ARVO board of trustees
New York-Robert Ritch, MD, surgeon, director, and chief of glaucoma services at The New York Eye and Ear Infirmary, will serve a 5-year term as a trustee of the Association for Research in Vision and Ophthalmology (ARVO).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
4
PainReform launches development plan for OcuRing-K, readies phase 2 trial
5















































.png)


